Horizon Therapeutics Public Ltd Co

ProShare Advisors LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

20,933

Value ($000)

2,422

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	2,422	0.0%	20,933	9/30/2023
2023 Q2	8/10/2023	1,839	0.0%	17,882	6/30/2023
2023 Q1	5/26/2023	2,065	0.0%	18,924	3/31/2023
2022 Q4	2/2/2023	2,524	0.0%	22,179	12/31/2022
2022 Q3	11/7/2022	1,426	0.0%	23,049	9/30/2022
2022 Q2	8/1/2022	1,728	0.0%	21,666	6/30/2022
2022 Q1	5/10/2022	3,015	0.0%	28,662	3/31/2022
2021 Q4	2/8/2022	4,056	0.0%	37,637	12/31/2021
2021 Q3	11/12/2021	5,872	0.0%	53,606	9/30/2021
2021 Q2	8/13/2021	4,543	0.0%	48,511	6/30/2021
2021 Q1	5/14/2021	3,240	0.0%	35,201	3/31/2021
2020 Q4	2/9/2021	2,782	0.0%	38,026	12/31/2020
2020 Q3	11/13/2020	3,016	0.0%	38,829	9/30/2020
2020 Q2	8/3/2020	1,865	0.0%	33,564	6/30/2020
2020 Q1	5/15/2020	865	0.0%	29,213	3/31/2020
2019 Q4	2/12/2020	1,629	0.0%	44,991	12/31/2019